# Declining insulin sensitivity is a key pathological contributor to dysglycemia: a longitudinal validation study in the Korean genome and epidemiology study

**Authors:** Doohwa Kim, Jinmi Kim, Myungsoo Im, Soree Ryang, Minsoo Kim, Yeong Jin Kim, In Joo Kim, Young Jin Kim, Hyuk Kang, Stephane T. Chung, Arthur S. Sherman, Sang Soo Kim, Joon Ha

PMC · DOI: 10.3389/fendo.2025.1726006 · Frontiers in Endocrinology · 2026-01-05

## TL;DR

This study shows that worsening insulin sensitivity, not just beta-cell function, is a key factor in diabetes progression among lean individuals.

## Contribution

The study demonstrates that declining insulin sensitivity independently predicts diabetes progression in lean individuals, even when beta-cell function is considered.

## Key findings

- Participants who progressed to diabetes showed greater insulin sensitivity decline than non-progressors.
- The effect of insulin sensitivity decline on diabetes risk exceeded that of beta-cell function deterioration.
- Lifestyle interventions to preserve insulin sensitivity are crucial for diabetes prevention in those with low beta-cell function.

## Abstract

The role of worsening insulin resistance (IR) in type 2 diabetes (T2D) progression among lean individuals is not well understood. We examined whether declining insulin sensitivity (IS), independent of beta-cell function (BCF), is associated with diabetes progression.

In a 10-year longitudinal Korean cohort with normal glucose tolerance (N = 2,810; age 50 ± 8y; BMI 24.1 ± 2.8 kg/m²), participants underwent biannual oral glucose tolerance tests. Longitudinal changes in IS, BCF, BMI, and fat mass were evaluated. Participants were stratified by baseline BCF (low/high), diabetes progression status (non-progressors [Non-p], progressors to prediabetes [PreDM-p], or T2D [T2D-p] over time), and degree of IS decline (large/small).

Both T2D-p and PreDM-p showed greater IS decline than Non-p. At baseline, PreDM-p had IS comparable to T2D-p, but T2D-p declined more steeply. T2D-p and PreDM-p also had lower BCF at baseline, which remained low. Across baseline BCF groups (high/low), greater IS decline was consistently associated with higher risk of progression (all P<0.001). The effect size of IS decline exceeded that of BCF deterioration.

Declining IS, independent of BCF, is associated with progression to T2D in lean Koreans. Preserving IS through lifestyle interventions is crucial for diabetes prevention, particularly in those with low BCF. Insulin resistance, β-cell function, disposition index, oral glucose tolerance test, body mass index.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), prediabetes (MONDO:0006920)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** diabetes (MESH:D003920), IR (MESH:D007333), prediabetes (MESH:D011236), T2D (MESH:D003924)
- **Chemicals:** glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12812719/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12812719/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12812719/full.md

---
Source: https://tomesphere.com/paper/PMC12812719